Cargando…

MOG cell-based assay detects non-MS patients with inflammatory neurologic disease

OBJECTIVE: To optimize sensitivity and disease specificity of a myelin oligodendrocyte glycoprotein (MOG) antibody assay. METHODS: Consecutive sera (n = 1,109) sent for aquaporin-4 (AQP4) antibody testing were screened for MOG antibodies (Abs) by cell-based assays using either full-length human MOG...

Descripción completa

Detalles Bibliográficos
Autores principales:	Waters, Patrick, Woodhall, Mark, O'Connor, Kevin C., Reindl, Markus, Lang, Bethan, Sato, Douglas K., Juryńczyk, Maciej, Tackley, George, Rocha, Joao, Takahashi, Toshiyuki, Misu, Tatsuro, Nakashima, Ichiro, Palace, Jacqueline, Fujihara, Kazuo, Leite, M. Isabel, Vincent, Angela
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2015
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4370386/ https://www.ncbi.nlm.nih.gov/pubmed/25821844 http://dx.doi.org/10.1212/NXI.0000000000000089

Ejemplares similares

Metabolomics reveals distinct, antibody-independent, molecular signatures of MS, AQP4-antibody and MOG-antibody disease
por: Jurynczyk, Maciej, et al.
Publicado: (2017)

MOG antibody–positive, benign, unilateral, cerebral cortical encephalitis with epilepsy
por: Ogawa, Ryo, et al.
Publicado: (2017)

CSF cytokine profile in MOG-IgG+ neurological disease is similar to AQP4-IgG+ NMOSD but distinct from MS: a cross-sectional study and potential therapeutic implications
por: Kaneko, Kimihiko, et al.
Publicado: (2018)

Difference in the Source of Anti-AQP4-IgG and Anti-MOG-IgG Antibodies in CSF in Patients With Neuromyelitis Optica Spectrum Disorder
por: Akaishi, Tetsuya, et al.
Publicado: (2021)

Frequency of MOG-IgG in cerebrospinal fluid versus serum
por: Pace, Samuel, et al.
Publicado: (2022)

Progressive patterns of neurological disability in multiple sclerosis and neuromyelitis optica spectrum disorders
por: Akaishi, Tetsuya, et al.
Publicado: (2020)

Contrasting the brain imaging features of MOG-antibody disease, with AQP4-antibody NMOSD and multiple sclerosis
por: Messina, Silvia, et al.
Publicado: (2021)

Recent developments in MOG-IgG associated neurological disorders
por: Hegen, Harald, et al.
Publicado: (2020)

International multicenter examination of MOG antibody assays
por: Reindl, Markus, et al.
Publicado: (2020)

Epitope Analysis of Cerebrospinal Fluid IgG in Japanese Multiple Sclerosis Patients Using Phage Display Method
por: Fujimori, Juichi, et al.
Publicado: (2011)

Number of MRI T1-hypointensity corrected by T2/FLAIR lesion volume indicates clinical severity in patients with multiple sclerosis
por: Akaishi, Tetsuya, et al.
Publicado: (2020)

CH50 as a putative biomarker of eculizumab treatment in neuromyelitis optica spectrum disorder
por: Namatame, Chihiro, et al.
Publicado: (2021)

A 41-year-old woman with acute weakness and encephalopathy associated with MOG antibodies
por: Morris, Katrina A., et al.
Publicado: (2015)

Classifying the antibody-negative NMO syndromes: Clinical, imaging, and metabolomic modeling
por: Yeo, Tianrong, et al.
Publicado: (2019)

Fingolimod-associated PML with mild IRIS in MS: A clinicopathologic study
por: Nishiyama, Shuhei, et al.
Publicado: (2017)

MOG antibody-associated diseases
por: Reindl, Markus, et al.
Publicado: (2015)

Aquaporin-4 antibody-positive myelitis initially biopsied for suspected spinal cord tumors: Diagnostic considerations
por: Sato, Douglas Kazutoshi, et al.
Publicado: (2013)

Evaluation of brain lesion distribution criteria at disease onset in differentiating MS from NMOSD and MOG-IgG-associated encephalomyelitis
por: Hyun, Jae-Won, et al.
Publicado: (2018)

Antibodies to MOG in adults with inflammatory demyelinating disease of the CNS
por: Kim, Sung-Min, et al.
Publicado: (2015)

Early Treatment Initiation With Oral Prednisolone for Relapse Prevention Alleviates Depression and Fatigue in Aquaporin-4–Positive Neuromyelitis optica Spectrum Disorder
por: Akaishi, Tetsuya, et al.
Publicado: (2021)

Optic neuritis after ocular trauma in anti‐aquaporin‐4 antibody‐positive neuromyelitis optica spectrum disorder
por: Akaishi, Tetsuya, et al.
Publicado: (2021)

Relapse activity in the chronic phase of anti-myelin-oligodendrocyte glycoprotein antibody-associated disease
por: Akaishi, Tetsuya, et al.
Publicado: (2021)

Circulating AQP4-specific auto-antibodies alone can induce neuromyelitis optica spectrum disorder in the rat
por: Hillebrand, Sophie, et al.
Publicado: (2018)

MOG-expressing teratoma followed by MOG-IgG-positive optic neuritis
por: Wildemann, Brigitte, et al.
Publicado: (2020)

Neurological update: MOG antibody disease
por: Wynford-Thomas, Ray, et al.
Publicado: (2018)

MOG Antibody-Associated Disorders Following SARS-CoV-2 Vaccination: A Case Report and Literature Review
por: Matsumoto, Yuki, et al.
Publicado: (2022)

Reversible paraspinal muscle hyperintensity in anti-MOG antibody–associated transverse myelitis
por: Pandit, Lekha, et al.
Publicado: (2017)

Double-negative neuromyelitis optica spectrum disorder
por: Wu, Yan, et al.
Publicado: (2023)

Differential Binding of Autoantibodies to MOG Isoforms in Inflammatory Demyelinating Diseases
por: Schanda, Kathrin, et al.
Publicado: (2021)

Aquaporin 4-specific T cells and NMO-IgG cause primary retinal damage in experimental NMO/SD
por: Zeka, Bleranda, et al.
Publicado: (2016)

Pathology of myelin oligodendrocyte glycoprotein antibody-associated disease: a comparison with multiple sclerosis and aquaporin 4 antibody-positive neuromyelitis optica spectrum disorders
por: Takai, Yoshiki, et al.
Publicado: (2023)

No strong HLA association with MOG antibody disease in the UK population
por: Grant‐Peters, Melissa, et al.
Publicado: (2021)

MOG encephalomyelitis: international recommendations on diagnosis and antibody testing
por: Jarius, S., et al.
Publicado: (2018)

Predictors of relapse in MOG antibody associated disease: a cohort study
por: Huda, Saif, et al.
Publicado: (2021)

ADEM-like presentation, anti-MOG antibodies, and MS pathology: TWO case reports
por: Körtvélyessy, Peter, et al.
Publicado: (2017)

Severely exacerbated neuromyelitis optica rat model with extensive astrocytopathy by high affinity anti-aquaporin-4 monoclonal antibody
por: Kurosawa, Kazuhiro, et al.
Publicado: (2015)

Outcome prediction models in AQP4-IgG positive neuromyelitis optica spectrum disorders
por: Palace, Jacqueline, et al.
Publicado: (2019)

A multicenter comparison of MOG-IgG cell-based assays
por: Waters, Patrick J., et al.
Publicado: (2019)

Intrastriatal injection of interleukin-1 beta triggers the formation of neuromyelitis optica-like lesions in NMO-IgG seropositive rats
por: Kitic, Maja, et al.
Publicado: (2013)

Factors associated with fatigue in CNS inflammatory diseases with AQP4 and MOG antibodies
por: Yeo, Tianrong, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_vvl69ii2au8fvdd4vfrrjcb2pj